Epigral
NSE: EPIGRAL · ISIN INE071N01016 · Basic Materials
₹898.20−14.95 (−1.64%)
Monday 9 November, 13:31 IST. Delayed. Source: Yahoo Finance.
Price chart
₹898.20 −14.95 (−1.64%) today
The day
- Previous close
- ₹913.15
- Open
- ₹923.00
- Day high
- ₹924.65
- Day low
- ₹894.90
Listed on NSE since 18 August 2021.
Key numbers
- Market value
- ₹3,874.95 Cr
- P/E (trailing)
- 13.60
- EPS (trailing)
- ₹66.03
- Price to book
- 1.64
- Dividend yield
- 0.55%
- Return on equity
- 12.8%
- Debt to equity
- 0.24
- Profit margin
- 10.2%
- Beta
- 0.30
- Volume today
- 38,284
- Average volume
- 58,278
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹2,169.44 Cr | ₹353.29 Cr |
| FY24 | ₹1,893.83 Cr | ₹195.87 Cr |
| FY25 | ₹2,514.40 Cr | ₹357.69 Cr |
| FY26 | ₹2,495.48 Cr | ₹331.97 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹746 Cr | ₹65 Cr | +27.1% |
| Q1 FY27Apr–Jun 2026 | ₹705 Cr | ₹100 Cr | −37.9% |
| Q4 FY26Jan–Mar 2026Audited | ₹736 Cr | ₹81 Cr | −6.8% |
| Q3 FY26Oct–Dec 2025 | ₹597 Cr | ₹39 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹587 Cr | ₹51 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹607 Cr | ₹161 Cr | – |
Source: Epigral’s results filed with NSE, consolidated (the whole group). Net profit is the share of Epigral’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹2,545 Cr | ₹2,553 Cr |
| Investments | ₹0 | ₹0 |
| Inventories | ₹365 Cr | ₹349 Cr |
| Owed by customers | ₹396 Cr | ₹417 Cr |
| Cash and equivalents | ₹86.00 L | ₹5 Cr |
| Total assets | ₹3,585 Cr | ₹3,505 Cr |
| Borrowings | ₹565 Cr | ₹563 Cr |
| Total liabilities | ₹1,221 Cr | ₹1,284 Cr |
| Shareholders’ equity | ₹2,365 Cr | ₹2,221 Cr |
Source: Epigral’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Epigral
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
- Industry
- Chemicals
- Based in
- Ahmedabad
- Employees
- 1,135
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Epigral in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 5 Per Share
Dividend · ex-date 1 June 2026
- Dividend - Rs 3.50 Per Share
Dividend · ex-date 20 June 2025 · record date 21 June 2025
- Interim Dividend - Rs 2.50 Per Share
Dividend · ex-date 7 February 2025
- Annual General Meeting/Dividend - Rs 5 Per Share
Dividend · ex-date 2 July 2024
- Annual General Meeting
Action · ex-date 20 June 2023
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 20 June 2023
- Interim Dividend - Rs 2.50 Per Share
Dividend · ex-date 1 February 2023
- Annual General Meeting
Action · ex-date 17 June 2022
Source: NSE. Latest first, 8 of 9.
Information only, not investment advice. Prices are delayed.